TWINSTRAND
LIVE

Serial Number

97357340

Owner

TwinStrand Biosciences, Inc.

Attorney

Monica Riva Talley

Filing Date

Apr 11, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TWINSTRAND Trademark

Serial Number: 97357340

TWINSTRAND is a trademark filed by TwinStrand Biosciences, Inc. on April 11, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

TwinStrand Biosciences, Inc. (13 trademarks)

Suite 750
Seattle, WA 98121

Entity Type: 03

Trademark Details

Filing Date

April 11, 2022

Registration Date

Not Registered

Published for Opposition

March 21, 2023

Goods & Services

Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; consulting and testing services in the field of genetic sequencing for medical, diagnostic and treatment purposes; providing medical genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer and other diseases; providing a website featuring medical information regarding genetics for educational purposes

genome sequencing and analysis services for forensic science purposes; providing temporary use of non-downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, molecular diagnostics, forensics, and consumer genomics

medical diagnostic reagents; clinical diagnostic reagents for medical purposes; diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing for medical purposes; medical diagnostic assays for medical and diagnostic purposes; medical diagnostic reagents and assays for testing body fluids; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes

Kits comprising primarily of reagents, enzymes and nucleotides for forensic research; diagnostic reagents for clinical laboratory use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2025 EXRA
SOU EXTENSION 5 GRANTED
Nov 18, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Nov 17, 2025 EEXT
SOU EXTENSION 5 FILED
Nov 16, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 17, 2025 EX4G
SOU EXTENSION 4 FILED
May 16, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2025 EXRA
SOU EXTENSION 3 GRANTED
Feb 11, 2025 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 10, 2025 AITU
SOU EXTENSION 3 FILED
Nov 18, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 15, 2024 EX2G
SOU EXTENSION 2 FILED
May 15, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 27, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 27, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 15, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 15, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 15, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 15, 2023 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Dec 12, 2022 GPRN
PRIORITY ACTION E-MAILED
Dec 12, 2022 GPRA
PRIORITY ACTION WRITTEN
Dec 12, 2022 CPRA
ASSIGNED TO EXAMINER
Dec 6, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2022 NWOS
NEW APPLICATION ENTERED
Apr 14, 2022 NWAP